iHuman Second Quarter 2025 Earnings: EPS: CN¥0.62 (vs CN¥0.47 in 2Q 2024)

Simply Wall St.09-20

AdvertisementiHuman (NYSE:IH) Second Quarter 2025 ResultsKey Financial Results Revenue: CN¥200.2m (down 6.9% from 2Q 2024). Net income: CN¥31.9m (up 29% from 2Q 2024). Profit margin: 16% (up from 12% ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2568177432?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/8043000-choice1-main-header/1585186853880","is_english":true,"pubTime":"2025-09-20 20:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2568177432","market":"sg","top_or_hot":-1,"title":"iHuman Second Quarter 2025 Earnings: EPS: CN¥0.62 (vs CN¥0.47 in 2Q 2024)","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementiHuman (NYSE:IH) Second Quarter 2025 ResultsKey Financial Results Revenue: CN¥200.2m (down 6.9% from 2Q 2024). Net income: CN¥31.9m (up 29% from 2Q 2024). Profit margin: 16% (up from 12% ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/media/nyse-ih/ihuman/news/ihuman-second-quarter-2025-earnings-eps-cn062-vs-cn047-in-2q\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>iHuman Second Quarter 2025 Earnings: EPS: CN¥0.62 (vs CN¥0.47 in 2Q 2024)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\niHuman Second Quarter 2025 Earnings: EPS: CN¥0.62 (vs CN¥0.47 in 2Q 2024)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-20 20:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/media/nyse-ih/ihuman/news/ihuman-second-quarter-2025-earnings-eps-cn062-vs-cn047-in-2q><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementiHuman (NYSE:IH) Second Quarter 2025 ResultsKey Financial Results Revenue: CN¥200.2m (down 6.9% from 2Q 2024). Net income: CN¥31.9m (up 29% from 2Q 2024). Profit margin: 16% (up from 12% ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/media/nyse-ih/ihuman/news/ihuman-second-quarter-2025-earnings-eps-cn062-vs-cn047-in-2q\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CN","symbol_name":"Xtrackers MSCI All China Equity ETF","start_time":0,"source_url":"https://simplywall.st/stocks/us/media/nyse-ih/ihuman/news/ihuman-second-quarter-2025-earnings-eps-cn062-vs-cn047-in-2q","article_id":"2568177432","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/8043000-choice1-main-header/1585186853880"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/media/nyse-ih/ihuman/news/ihuman-second-quarter-2025-earnings-eps-cn062-vs-cn047-in-2q","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2568177432","pubTimestamp":1758369928,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"iHuman ( NYSE:IH ) Second Quarter 2025 Results Key Financial Results Revenue: CN¥200.2m (down 6.9% from 2Q 2024). Net...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CN":"Xtrackers MSCI All China Equity ETF","IH":"洪恩"},"translate_title":"iHuman 2025年第二季度收益：每股收益：0.62元人民币（2024年第二季度为0.47元人民币）","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CN":1.5,"IH":1.5},"content_text":"AdvertisementiHuman (NYSE:IH) Second Quarter 2025 ResultsKey Financial Results Revenue: CN¥200.2m (down 6.9% from 2Q 2024). Net income: CN¥31.9m (up 29% from 2Q 2024). Profit margin: 16% (up from 12% in 2Q 2024). The increase in margin was driven by lower expenses. EPS: CN¥0.62 (up from CN¥0.47 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. NYSE:IH Earnings and Revenue History September 20th 2025 All figures shown in the chart above are for the trailing 12 month (TTM) period iHuman's share price is broadly unchanged from a week ago.   Risk Analysis We should say that we've discovered 1 warning sign for iHuman that you should be aware of before investing here. Valuation is complex, but we're here to simplify it.Discover if iHuman might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2568177432","isCrawlerRequest":true}